Biochemistry, Genetics and Molecular Biology
Catecholaminergic Polymorphic Ventricular Tachycardia
100%
Mutant
72%
Allele
72%
Calcium
54%
Homeostasis
54%
RNA
54%
Minigene
54%
Bioinformatics
54%
Wild Type
54%
Genetic Divergence
54%
Ion Channels
40%
Data Base
32%
Electrochemical Gradient
27%
Ion Current
27%
Action Potential
27%
Sleep
21%
Position
21%
Amino Acids
21%
Ryanodine Receptor 2
20%
Reduction (Chemistry)
18%
Carvedilol
18%
Nebivolol
18%
Bigeminy
18%
Molecular Genetics
18%
Life
18%
Screening
18%
Genotyping
18%
Missense Mutation
18%
Sudden Cardiac Death
18%
Mutation
18%
Exercise
18%
Genetic Screening
18%
Emotional Stress
18%
Emotion
18%
Flow
13%
Sarcolemma
13%
Cardiac Electrophysiology
13%
Channelopathy
13%
Computer Model
10%
Classification
10%
Minor Allele Frequency
10%
Sequence Database
10%
Medical Genomics
10%
Ion Transport
10%
C-Terminus
10%
Phenotype
10%
Protein
10%
Messenger RNA
9%
Cardiac Arrest
9%
Induced Pluripotent Stem Cell
9%
Medicine and Dentistry
Cardiovascular Risk
54%
Isotopes of Calcium
54%
Family
54%
Catecholaminergic Polymorphic Ventricular Tachycardia
45%
Patient
36%
Deterioration
36%
Adverse Outcome
36%
Life
36%
Diagnosis
36%
Faintness
36%
Therapeutic Procedure
27%
Mutant
18%
Diseases
18%
Metabolism
18%
Sibling
18%
Survival
18%
Age
18%
Attention
18%
Carvedilol
18%
Serositis
18%
Weight Loss
18%
Feeding
18%
Sudden Death
18%
Emotion
18%
Exercise
18%
Sudden Unexpected Death in Epilepsy
18%
Emotional Stress
18%
Sudden Cardiac Death
18%
Genetic Screening
18%
Missense Mutation
18%
Screening
18%
Ryanodine Receptor 2
9%
Heart Ventricle Arrhythmia
9%
Heart Arrest
9%
Messenger RNA
9%
Calcium Signaling
9%
Isoprenaline
9%
Cardiomyocyte
9%
Receptor Gene
9%
Induced Pluripotent Stem Cell
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Risk
54%
Dabigatran
54%
Warfarin
42%
Deterioration
36%
Adverse Outcome
36%
Malnutrition
36%
Survival
18%
Inflammation
18%
Frailty
18%
Atrial Fibrillation
18%
Drug
18%
Clinical Trial
6%
Observational Study
6%
Complication
6%